Emerging evidence has indicated that the upregulation of glomerular MCP-1 during the proliferative phase of glomerulonephritis is, at least in part, due to the NF-κB dependent signaling pathway [43], [44]. The gene discussed is CCL2; the disease is glomerulonephritis.